Table 1 Cancer and chemotherapeutic parameters
From: Cardio-toxicity among patients with sarcoma: a cardio-oncology registry
All (n = 43) | non-CTRCD (n = 37) | CTRCD (n = 6) | |
|---|---|---|---|
Soft Tissue Sarcoma (n, %) | 31 (72) | 27 (72) | 4 (67) |
Metastatic (n, %) | 26 (60) | 21 (57) | 5 (83) |
Anthracycline dose mg/m2 (mean, SD) | 337(±159) | 328(±149) | 388(±223) |
Dexrazoxane (n, %) | 25 (58) | 21 (57) | 4 (67) |
Ifosfamide (n, %) | 25 (58) | 19 (51) | 6 (100) |